Anne Hamilton is the founder and executive director of the Survivorship Collective, the first non-profit connecting the cancer community to safe, regulated, psychedelic-assisted therapies. Aftersurviving advanced-stage cancer as a young adult, she became an advocate for better mentaland spiritual care for cancer patients, survivors, and their loved ones. Hamilton is a formerlitigator, 9th Circuit Clerk, and a current member of the Psychedelic Bar Association. She hasworked in government, with nonprofits, and in higher education as a professor at USC’s Schoolof Cinematic Arts. She is a 2025 Mira Fellow, a certified mediator, holds a J.D. from Yale LawSchool, a Master’s Degree in Philosophy from Stanford University, and is a graduate of NotreDame and the American Film Institute.

Danielle Nova is a world-leading expert in microdosing and psychedelic-assisted approaches for addiction recovery. She is the Executive Director of the first and largest psychedelic society in the United States, San Francisco Psychedelic Society, as well as the Founder of Lumeria and the Microdosing Facilitator Training, the first such certification training in North America.

Danielle transformed her life out of 15 years of severe drug addiction through the intentional useof psychedelics and microdosing. She went on to foundPsychedelic Recovery, a harm reduction peer support group that has provided integration services for thousands of individuals around the globe who are utilizing psychedelics to interrupt addictive patterns.

As a leader in the field, Danielle has professionally trained and certified over 100 clinicians, coaches and wellness practitioners to become ethical, trauma-informed microdosing facilitators. With nearly a decade of experience, Danielle has made a significant global impact by creating and delivering educational programs, integration groups and addiction recovery services to more than 25,000 individuals worldwide.

Danielle was also instrumental in working on the founding team of Decriminalize NatureOakland, which passed the first resolution in the United States to deprioritize all entheogenic plants and fungi. Featured in esteemed outlets such as CBS News, SXSW and the MAPS Psychedelic Science Conference, Danielle is a trailblazer in microdosing training, advocacy and addiction treatment.

Jesse Gould, a former Army Ranger and Founder of Heroic Hearts Project, is leading the charge when it comes to providing psychedelic therapy to military veterans. Through his nonprofit, he has raised over $10 million and served more than 1,500 veterans and veteran spouses. Partnering with top institutions like the University of Georgia and Imperial College London, Jesse continues to further research on psychedelic treatments for PTSD and TraumaticBrain Injury. His work, featured in outlets like the New York Times and Forbes, has earned him recognition as the "Godfather of psychedelics for veterans," making him a global advocate for reshaping mental health care for those who have sacrificed so much.

Juliana Mulligan, LMSW, is a psychotherapist who is formerly opioid dependent, formerly incarcerated, and has been working in the ibogaine treatment community for fourteen years. In 2011, with the help of ibogaine treatment, Juliana left opioids behind and set off on a path to transform the way drug users and their treatment is approached. She has a master’s in social work from NYU, was previously the Psychedelic Program Coordinator at the Center for Optimal Living, and is a consultant for Americans for Ibogaine. She currently runs Inner Vision Ibogaine, which supports people in preparation and integration around ibogaine treatment and offers consulting services to ibogaine related projects. She is also the founder of Idryma, the first ibogaine facilitator training program. She has worked in multiple ibogaine clinics, presented at many psychedelic and harm reduction conferences, and is the author of the Guide to Finding aSafe Ibogaine Clinic and co-author of Fireside’s Warning Signs When Selecting a Psychedelic Facilitator. She has taught about ibogaine at Charite University in Berlin and SouthwesternCollege in New Mexico and has written for multiple publications about ibogaine. She has also been quoted in the New York Times, Rolling Stone, National Geographic, and Reason Magazine.

Richard Harris is a Susan Samueli Endowed Chair in the Susan Samueli Integrative Health Institute and Professor in the Department of Anesthesiology and Perioperative Care in the School of Medicine at the University of California at Irvine. His background is in basic science and clinical research in alternative medicine. He received his B.S. degree in Genetics from Purdue University in 1992 and his Ph. D. in Molecular and Cell Biology from UC Berkeley in 1997. Following his graduate work, he completed a postdoctoral fellowship at NIH. He is a graduate of the Maryland Institute of Traditional Chinese Medicine and has received an MS degree in Clinical Research Design and Statistical Analysis at the University of Michigan. Dr.Harris is currently investigating mechanisms of chronic pain and its treatment with acupuncture, psychedelics, energy healing, and shamanism. His recent investigations have focused on the role of brain neurotransmitters and brain network behavior in chronic pain. He was a member of the National Advisory Council for NIH/NCCIH and is a past co-President for the Society forAcupuncture Research.